A scoping review shows machine learning models may help predict response to biologic and targeted synthetic DMARDs in ...
Machine learning model improves transplant risk assessment for patients with myelofibrosis, helping clinicians make informed decisions, as per an expert. A new machine learning model has significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback